Regulation of corneal angiogenesis in limbal stem cell deficiency

Progress in Retinal and Eye Research

Volumn 25, Issue 6, 2006, Pages 563-590

  Ma, David Hui Kang ^a,b   Chen, Jan Kan ^b   Zhang, Fen ^c   Lin, Kuei Ying ^a   Yao, Jeng Yuan ^a   Yu, Jau Song ^b  

^a CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

^b CHANG GUNG UNIVERSITY COLLEGE OF MEDICINE   (Taiwan)

^c Amniotech Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOSTATIN; CELL ADHESION MOLECULE; CHEMOKINE; CHEMOKINE RECEPTOR; COLLAGEN TYPE 15; COLLAGEN TYPE 18; COLLAGEN TYPE 4; CYTOKINE; ENDOSTATIN; ICOSANOID; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERSTITIAL COLLAGENASE; MATRIX METALLOPROTEINASE; MONOKINE; PHOSPHORYLCHOLINE; PROTEIN 14 3 3; RESTIN; STROMELYSIN; THROMBOCYTE ACTIVATING FACTOR; TISSUE INHIBITOR OF METALLOPROTEINASE; TISSUE INHIBITOR OF METALLOPROTEINASE 4; VASCULAR CELL ADHESION MOLECULE 1; VASCULOTROPIN; VASCULOTROPIN C; VASCULOTROPIN RECEPTOR 3;

AMNION; ANGIOGENESIS; CELL CULTURE; CELL CYCLE REGULATION; CONJUNCTIVA; CORNEA DISEASE; CORNEA EPITHELIUM; CORNEA INJURY; CORNEA NEOVASCULARIZATION; CORNEA VASCULARIZATION; CYTOKINE PRODUCTION; EPITHELIUM CELL; HISTOPATHOLOGY; HUMAN; INFLAMMATION; KERATINOCYTE; LIMBAL STEM CELL DEFICIENCY; LIMBAL STEM CELL TRANSPLANTATION; LYMPHANGIOGENESIS; MEDIATOR RELEASE; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN FUNCTION; PROTEOMICS; REVIEW; TREATMENT OUTCOME; WOUND HEALING;

ANIMALS; CORNEAL NEOVASCULARIZATION; EXTRACELLULAR MATRIX PROTEINS; HUMANS; LIMBUS CORNEAE; STEM CELLS;

EID: 33750494958     PISSN: 13509462     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.preteyeres.2006.09.001     Document Type: Review

References (268)

1. Abraham S., Sawaya B.E., Safak M., Batuman O., Khalili K., and Amini S. Regulation of MCP-1 gene transcription by Smads and HIV-1 Tat in human glial cells. Virology 309 (2003) 196-202
2. Achen M.G., Jeltsch M., Kukk E., Makinen T., Vitali A., Wilks A.F., Alitalo K., and Stacker S.A. Vascular endothelial growth factor D (VEGF-D) is a ligand for the tyrosine kinases VEGF receptor 2 (Flk1) and VEGF receptor 3 (Flt4). Proc. Natl. Acad. Sci. USA 95 (1998) 548-553
3. Adamis A.P., Meklir B., and Joyce N.C. In situ injury-induced release of basic-fibroblast growth factor from corneal epithelial cells. Am. J. Pathol. 139 (1991) 961-967
4. Amano S., Rohan R., Kuroki M., Tolentino M., and Adamis A.P. Requirement for vascular endothelial growth factor in wound- and inflammation-related corneal neovascularization. Invest Ophthalmol. Vis. Sci. 39 (1998) 18-22
5. Ambati B.K., Anand A., Joussen A.M., Kuziel W.A., Adamis A.P., and Ambati J. Sustained inhibition of corneal neovascularization by genetic ablation of CCR5. Invest Ophthalmol. Vis. Sci. 44 (2003) 590-593
6. Ambati B.K., Joussen A.M., Kuziel W.A., Adamis A.P., and Ambati J. Inhibition of corneal neovascularization by genetic ablation of CCR2. Cornea 22 (2003) 465-467
7. Anand-Apte B., Pepper M.S., Voest E., Montesano R., Olsen B., Murphy G., Apte S.S., and Zetter B. Inhibition of angiogenesis by tissue inhibitor of metalloproteinase-3. Invest Ophthalmol. Vis. Sci. 38 (1997) 817-823
8. Armstrong D.J., Hiscott P., Batterbury M., and Kaye S. Corneal stromal cells (keratocytes) express thrombospondins 2 and 3 in wound repair phenotype. Int. J. Biochem. Cell Biol. 34 (2002) 588-593
9. Armstrong D.J., Hiscott P., Batterbury M., and Kaye S. Keratocyte matrix interactions and thrombospondin 2. Mol. Vis. 9 (2003) 74-79
10. Ashcroft G.S., Yang X., Glick A.B., Weinstein M., Letterio J.L., Mizel D.E., Anzano M., Greenwell-Wild T., Wahl S.M., Deng C., and Roberts A.B. Mice lacking Smad3 show accelerated wound healing and an impaired local inflammatory response. Nat. Cell Biol. 1 (1999) 260-266
11. Bazan H., and Ottino P. The role of platelet-activating factor in the corneal response to injury. Prog. Retin. Eye Res. 21 (2002) 449-464
12. Bazan H.E. Cellular and molecular events in corneal wound healing: significance of lipid signalling. Exp. Eye Res. 80 (2005) 453-463
13. Bazan H.E., Reddy S.T., and Lin N. Platelet-activating factor (PAF) accumulation correlates with injury in the cornea. Exp. Eye Res. 52 (1991) 481-491
14. Bazan H.E., and Tao Y. PAF antagonists as possible inhibitors of corneal epithelial defects and ulceration. J. Ocul. Pharmacol. Ther. 13 (1997) 277-285
15. Becker M.D., Kruse F.E., Azzam L., Nobiling R., Reichling J., and Volcker H.E. In vivo significance of ICAM-1-dependent leukocyte adhesion in early corneal angiogenesis. Invest Ophthalmol. Vis. Sci. 40 (1999) 612-618
16. Berger O., Gan X., Gujuluva C., Burns A.R., Sulur G., Stins M., Way D., Witte M., Weinand M., Said J., Kim K.S., Taub D., Graves M.C., and Fiala M. CXC and CC chemokine receptors on coronary and brain endothelia. Mol. Med. 5 (1999) 795-805
17. Bhutto I.A., Kim S.Y., McLeod D.S., Merges C., Fukai N., Olsen B.R., and Lutty G.A. Localization of collagen XVIII and the endostatin portion of collagen XVIII in aged human control eyes and eyes with age-related macular degeneration. Invest Ophthalmol. Vis. Sci. 45 (2004) 1544-1552
18. Biswas P.S., Banerjee K., Kinchington P.R., and Rouse B.T. Involvement of IL-6 in the paracrine production of VEGF in ocular HSV-1 infection. Exp. Eye Res. 82 (2006) 46-54
19. Bix G., and Iozzo R.V. Matrix revolutions: "tails" of basement-membrane components with angiostatic functions. Trends Cell Biol. 15 (2005) 52-60
20. Boisjoly H.M., Laplante C., Bernatchez S.F., Salesse C., Giasson M., and Joly M.C. Effects of EGF, IL-1 and their combination on in vitro corneal epithelial wound closure and cell chemotaxis. Exp. Eye Res. 57 (1993) 293-300
21. Boneham G.C., and Collin H.B. Steroid inhibition of limbal blood and lymphatic vascular cell growth. Curr. Eye Res. 14 (1995) 1-10
22. Brooks P.C., Stromblad S., Sanders L.C., von Schalscha T.L., Aimes R.T., Stetler-Stevenson W.G., Quigley J.P., and Cheresh D.A. Localization of matrix metalloproteinase MMP-2 to the surface of invasive cells by interaction with integrin alpha v beta 3. Cell 85 (1996) 683-693
23. Brown D., Chwa M.M., Opbroek A., and Kenney M.C. Keratoconus corneas: increased gelatinolytic activity appears after modification of inhibitors. Curr. Eye Res. 12 (1993) 571-581
24. Burwick N.R., Wahl M.L., Fang J., Zhong Z., Moser T.L., Li B., Capaldi R.A., Kenan D.J., and Pizzo S.V. An Inhibitor of the F1 subunit of ATP synthase (IF1) modulates the activity of angiostatin on the endothelial cell surface. J. Biol. Chem. 280 (2005) 1740-1745
25. Cameron M.J., and Kelvin D.J. Cytokines and chemokines-their receptors and their genes: an overview. Adv. Exp. Med. Biol. 520 (2003) 8-32
26. Cao Y. Endogenous angiogenesis inhibitors and their therapeutic implications. Int. J. Biochem. Cell Biol. 33 (2001) 357-369
27. Cao Y., Ji R.W., Davidson D., Schaller J., Marti D., Sohndel S., McCance S.G., O'Reilly M.S., Llinas M., and Folkman J. Kringle domains of human angiostatin. Characterization of the anti-proliferative activity on endothelial cells. J. Biol. Chem. 271 (1996) 29461-29467
28. Castro M.R., Lutz D., and Edelman J.L. Effect of COX inhibitors on VEGF-induced retinal vascular leakage and experimental corneal and choroidal neovascularization. Exp. Eye Res. 79 (2004) 275-285
29. Chang J.H., Javier J.A., Chang G.Y., Oliveira H.B., and Azar D.T. Functional characterization of neostatins, the MMP-derived, enzymatic cleavage products of type XVIII collagen. FEBS Lett. 579 (2005) 3601-3606
30. Chen J.J., and Tseng S.C. Corneal epithelial wound healing in partial limbal deficiency. Invest Ophthalmol. Vis. Sci. 31 (1990) 1301-1314
31. Chen J.J., and Tseng S.C. Abnormal corneal epithelial wound healing in partial-thickness removal of limbal epithelium. Invest Ophthalmol. Vis. Sci. 32 (1991) 2219-2233
32. Chen L., Cursiefen C., Barabino S., Zhang Q., and Dana M.R. Novel expression and characterization of lymphatic vessel endothelial hyaluronate receptor 1 (LYVE-1) by conjunctival cells. Invest Ophthalmol. Vis. Sci. 46 (2005) 4536-4540
33. Colorado P.C., Torre A., Kamphaus G., Maeshima Y., Hopfer H., Takahashi K., Volk R., Zamborsky E.D., Herman S., Sarkar P.K., Ericksen M.B., Dhanabal M., Simons M., Post M., Kufe D.W., Weichselbaum R.R., Sukhatme V.P., and Kalluri R. Anti-angiogenic cues from vascular basement membrane collagen. Cancer Res. 60 (2000) 2520-2526
34. Conners M.S., Urbano F., Vafeas C., Stoltz R.A., Dunn M.W., and Schwartzman M.L. Alkali burn-induced synthesis of inflammatory eicosanoids in rabbit corneal epithelium. Invest Ophthalmol. Vis. Sci. 38 (1997) 1963-1971
35. Corcoran M.L., Hewitt R.E., Kleiner Jr. D.E., and Stetler-Stevenson W.G. MMP-2: expression, activation and inhibition. Enzyme Protein 49 (1996) 7-19
36. Coussens L.M., and Werb Z. Inflammation and cancer. Nature 420 (2002) 860-867
37. Cursiefen C., Rummelt C., and Kuchle M. Immunohistochemical localization of vascular endothelial growth factor, transforming growth factor alpha, and transforming growth factor beta1 in human corneas with neovascularization. Cornea 19 (2000) 526-533
38. Cursiefen C., Schlotzer-Schrehardt U., Kuchle M., Sorokin L., Breiteneder-Geleff S., Alitalo K., and Jackson D. Lymphatic vessels in vascularized human corneas: immunohistochemical investigation using LYVE-1 and podoplanin. Invest Ophthalmol. Vis. Sci. 43 (2002) 2127-2135
39. Cursiefen C., Cao J., Chen L., Liu Y., Maruyama K., Jackson D., Kruse F.E., Wiegand S.J., Dana M.R., and Streilein J.W. Inhibition of hemangiogenesis and lymphangiogenesis after normal-risk corneal transplantation by neutralizing VEGF promotes graft survival. Invest Ophthalmol. Vis. Sci. 45 (2004) 2666-2673
40. Cursiefen C., Chen L., Borges L.P., Jackson D., Cao J., Radziejewski C., D'Amore P.A., Dana M.R., Wiegand S.J., and Streilein J.W. VEGF-A stimulates lymphangiogenesis and hemangiogenesis in inflammatory neovascularization via macrophage recruitment. J. Clin. Invest 113 (2004) 1040-1050
41. Dana M.R., Zhu S.N., and Yamada J. Topical modulation of interleukin-1 activity in corneal neovascularization. Cornea 17 (1998) 403-409
42. Detmar M., Yeo K.T., Nagy J.A., Van de W.L., Brown L.F., Berse B., Elicker B.M., Ledbetter S., and Dvorak H.F. Keratinocyte-derived vascular permeability factor (vascular endothelial growth factor) is a potent mitogen for dermal microvascular endothelial cells. J. Invest Dermatol. 105 (1995) 44-50
43. Dhanabal M., Ramchandran R., Waterman M.J., Lu H., Knebelmann B., Segal M., and Sukhatme V.P. Endostatin induces endothelial cell apoptosis. J. Biol. Chem. 274 (1999) 11721-11726
44. Dixelius J., Larsson H., Sasaki T., Holmqvist K., Lu L., Engstrom A., Timpl R., Welsh M., and Claesson-Welsh L. Endostatin-induced tyrosine kinase signaling through the Shb adaptor protein regulates endothelial cell apoptosis. Blood 95 (2000) 3403-3411
45. Dixelius J., Cross M., Matsumoto T., Sasaki T., Timpl R., and Claesson-Welsh L. Endostatin regulates endothelial cell adhesion and cytoskeletal organization. Cancer Res. 62 (2002) 1944-1947
46. Duh E.J., Yao Y.G., Dagli M., and Goldberg M.F. Persistence of fetal vasculature in a patient with Knobloch syndrome: potential role for endostatin in fetal vascular remodeling of the eye. Ophthalmology 111 (2004) 1885-1888
47. Edelman J.L., Castro M.R., and Wen Y. Correlation of VEGF expression by leukocytes with the growth and regression of blood vessels in the rat cornea. Invest Ophthalmol. Vis. Sci. 40 (1999) 1112-1123
48. Egeblad M., and Werb Z. New functions for the matrix metalloproteinases in cancer progression. Nat. Rev. Cancer 2 (2002) 161-174
49. Eklund L., Piuhola J., Komulainen J., Sormunen R., Ongvarrasopone C., Fassler R., Muona A., Ilves M., Ruskoaho H., Takala T.E., and Pihlajaniemi T. Lack of type XV collagen causes a skeletal myopathy and cardiovascular defects in mice. Proc. Natl. Acad. Sci. USA 98 (2001) 1194-1199
50. Espana E.M., Di Pascuale M.A., He H., Kawakita T., Raju V.K., Liu C.Y., and Tseng S.C. Characterization of corneal pannus removed from patients with total limbal stem cell deficiency. Invest Ophthalmol. Vis. Sci. 45 (2004) 2961-2966
51. Fantuzzi L., Borghi P., Ciolli V., Pavlakis G., Belardelli F., and Gessani S. Loss of CCR2 expression and functional response to monocyte chemotactic protein (MCP-1) during the differentiation of human monocytes: role of secreted MCP-1 in the regulation of the chemotactic response. Blood 94 (1999) 875-883
52. Felbor U., Dreier L., Bryant R.A., Ploegh H.L., Olsen B.R., and Mothes W. Secreted cathepsin L generates endostatin from collagen XVIII. EMBO J. 19 (2000) 1187-1194
53. Fernandez C.A., and Moses M.A. Modulation of angiogenesis by tissue inhibitor of metalloproteinase-4. Biochem. Biophys. Res. Commun. 345 (2006) 523-529
54. Ferreras M., Felbor U., Lenhard T., Olsen B.R., and Delaisse J. Generation and degradation of human endostatin proteins by various proteinases. FEBS Lett. 486 (2000) 247-251
55. Franke A.G., Gubbe C., Beier M., and Duenker N. Transforming growth factor-beta and bone morphogenetic proteins: cooperative players in chick and murine programmed retinal cell death. J. Comp Neurol. 495 (2006) 263-278
56. Frater-Schroder M., Risau W., Hallmann R., Gautschi P., and Bohlen P. Tumor necrosis factor type alpha, a potent inhibitor of endothelial cell growth in vitro, is angiogenic in vivo. Proc. Natl. Acad. Sci. USA 84 (1987) 5277-5281
57. Friedlander M., Brooks P.C., Shaffer R.W., Kincaid C.M., Varner J.A., and Cheresh D.A. Definition of two angiogenic pathways by distinct alpha v integrins. Science 270 (1995) 1500-1502
58. Friedlander M., Theesfeld C.L., Sugita M., Fruttiger M., Thomas M.A., Chang S., and Cheresh D.A. Involvement of integrins alpha v beta 3 and alpha v beta 5 in ocular neovascular diseases. Proc. Natl. Acad. Sci USA 93 (1996) 9764-9769
59. Fukai N., Eklund L., Marneros A.G., Oh S.P., Keene D.R., Tamarkin L., Niemela M., Ilves M., Li E., Pihlajaniemi T., and Olsen B.R. Lack of collagen XVIII/endostatin results in eye abnormalities. EMBO J. 21 (2002) 1535-1544
60. Gabison E., Chang J.H., Hernandez-Quintela E., Javier J., Lu P.C., Ye H., Kure T., Kato T., and Azar D.T. Anti-angiogenic role of angiostatin during corneal wound healing. Exp. Eye Res. 78 (2004) 579-589
61. Ghaffari A., Li Y., Karami A., Ghaffari M., Tredget E.E., and Ghahary A. Fibroblast extracellular matrix gene expression in response to keratinocyte-releasable stratifin. J. Cell Biochem. 98 (2006) 383-393
62. Ghahary A., Karimi-Busheri F., Marcoux Y., Li Y., Tredget E.E., Taghi K.R., Li L., Zheng J., Karami A., Keller B.O., and Weinfeld M. Keratinocyte-releasable stratifin functions as a potent collagenase-stimulating factor in fibroblasts. J. Invest Dermatol. 122 (2004) 1188-1197
63. Goede V., Brogelli L., Ziche M., and Augustin H.G. Induction of inflammatory angiogenesis by monocyte chemoattractant protein-1. Int. J. Cancer 82 (1999) 765-770
64. Gomez D.E., Alonso D.F., Yoshiji H., and Thorgeirsson U.P. Tissue inhibitors of metalloproteinases: structure, regulation and biological functions. Eur. J. Cell Biol. 74 (1997) 111-122
65. Grueterich M., Espana E.M., Touhami A., Ti S.E., and Tseng S.C. Phenotypic study of a case with successful transplantation of ex vivo expanded human limbal epithelium for unilateral total limbal stem cell deficiency. Ophthalmology 109 (2002) 1547-1552
66. Grueterich M., Espana E.M., and Tseng S.C. Ex vivo expansion of limbal epithelial stem cells: amniotic membrane serving as a stem cell niche. Surv. Ophthalmol. 48 (2003) 631-646
67. Haas T.L., Davis S.J., and Madri J.A. Three-dimensional type I collagen lattices induce coordinate expression of matrix metalloproteinases MT1-MMP and MMP-2 in microvascular endothelial cells. J. Biol. Chem. 273 (1998) 3604-3610
68. Halfter W., Dong S., Schurer B., and Cole G.J. Collagen XVIII is a basement membrane heparan sulfate proteoglycan. J. Biol. Chem. 273 (1998) 25404-25412
69. Hamano Y., Zeisberg M., Sugimoto H., Lively J.C., Maeshima Y., Yang C., Hynes R.O., Werb Z., Sudhakar A., and Kalluri R. Physiological levels of tumstatin, a fragment of collagen IV alpha3 chain, are generated by MMP-9 proteolysis and suppress angiogenesis via alphaV beta3 integrin. Cancer Cell 3 (2003) 589-601
70. Hamrah P., Chen L., Zhang Q., and Dana M.R. Novel expression of vascular endothelial growth factor receptor (VEGFR)-3 and VEGF-C on corneal dendritic cells. Am. J. Pathol. 163 (2003) 57-68
71. Hamrah P., Chen L., Cursiefen C., Zhang Q., Joyce N.C., and Dana M.R. Expression of vascular endothelial growth factor receptor-3 (VEGFR-3) on monocytic bone marrow-derived cells in the conjunctiva. Exp. Eye Res. 79 (2004) 553-561
72. Hanai J., Dhanabal M., Karumanchi S.A., Albanese C., Waterman M., Chan B., Ramchandran R., Pestell R., and Sukhatme V.P. Endostatin causes G1 arrest of endothelial cells through inhibition of cyclin D1. J. Biol. Chem. 277 (2002) 16464-16469
73. Hanai J., Gloy J., Karumanchi S.A., Kale S., Tang J., Hu G., Chan B., Ramchandran R., Jha V., Sukhatme V.P., and Sokol S. Endostatin is a potential inhibitor of Wnt signaling. J. Cell Biol. 158 (2002) 529-539
74. Hao Y., Ma D.H., Hwang D.G., Kim W.S., and Zhang F. Identification of antiangiogenic and antiinflammatory proteins in human amniotic membrane. Cornea 19 (2000) 348-352
75. Hayashi T., Matsuoka K., Saitoh M., Takeda S., and Kimura M. Influence of alpha-tumor necrosis factor and beta-interleukin-1 on production of angiogenetic factors and thymidine phosphorylase activity in immortalized human decidual fibroblasts in vitro. J. Obstet. Gynaecol. Res. 32 (2006) 15-22
76. Heiligenhaus A., Bauer D., Meller D., Steuhl K.P., and Tseng S.C. Improvement of HSV-1 necrotizing keratitis with amniotic membrane transplantation. Invest Ophthalmol. Vis. Sci. 42 (2001) 1969-1974
77. Hermeking H. Extracellular 14-3-3sigma protein: a potential mediator of epithelial-mesenchymal interactions. J. Invest Dermatol. 124 (2005) ix
78. Hermeking H., Lengauer C., Polyak K., He T.C., Zhang L., Thiagalingam S., Kinzler K.W., and Vogelstein B. 14-3-3 sigma is a p53-regulated inhibitor of G2/M progression. Mol. Cell 1 (1997) 3-11
79. Hiscott P., Schlotzer-Schrehardt U., and Naumann G.O. Unexpected expression of thrombospondin 1 by corneal and iris fibroblasts in the pseudoexfoliation syndrome. Hum. Pathol. 27 (1996) 1255-1258
80. Hiscott P., Sorokin L., Nagy Z.Z., Schlotzer-Schrehardt U., and Naumann G.O. Keratocytes produce thrombospondin 1: evidence for cell phenotype-associated synthesis. Exp. Cell Res. 226 (1996) 140-146
81. Hiscott P., Seitz B., Schlotzer-Schrehardt U., and Naumann G.O. Immunolocalisation of thrombospondin 1 in human, bovine and rabbit cornea. Cell Tissue Res. 289 (1997) 307-310
82. Hiscott P., Paraoan L., Choudhary A., Ordonez J.L., Al Khaier A., and Armstrong D.J. Thrombospondin 1, thrombospondin 2 and the eye. Prog. Retin. Eye Res. 25 (2006) 1-18
83. Huang A.J., and Tseng S.C. Corneal epithelial wound healing in the absence of limbal epithelium. Invest Ophthalmol. Vis. Sci. 32 (1991) 96-105
84. Huang A.J., Watson B.D., Hernandez E., and Tseng S.C. Induction of conjunctival transdifferentiation on vascularized corneas by photothrombotic occlusion of corneal neovascularization. Ophthalmology 95 (1988) 228-235
85. Hurskainen M., Eklund L., Hagg P.O., Fruttiger M., Sormunen R., Ilves M., and Pihlajaniemi T. Abnormal maturation of the retinal vasculature in type XVIII collagen/endostatin deficient mice and changes in retinal glial cells due to lack of collagen types XV and XVIII. FASEB J. 19 (2005) 1564-1566
86. Imaizumi T., Itaya H., Nasu S., Yoshida H., Matsubara Y., Fujimoto K., Matsumiya T., Kimura H., and Satoh K. Expression of vascular endothelial growth factor in human umbilical vein endothelial cells stimulated with interleukin-1alpha-an autocrine regulation of angiogenesis and inflammatory reactions. Thromb. Haemost. 83 (2000) 949-955
87. Itoh T., Tanioka M., Yoshida H., Yoshioka T., Nishimoto H., and Itohara S. Reduced angiogenesis and tumor progression in gelatinase A-deficient mice. Cancer Res. 58 (1998) 1048-1051
88. Izumi T., Honda Z., Mutoh H., Kume K., and Shimizu T. Regulation and signal transduction of PAF receptor. Adv. Prostaglandin Thromboxane Leukot. Res. 23 (1995) 461-466
89. Jester J.V., Huang J., Petroll W.M., and Cavanagh H.D. TGFbeta induced myofibroblast differentiation of rabbit keratocytes requires synergistic TGFbeta, PDGF and integrin signaling. Exp. Eye Res. 75 (2002) 645-657
90. Jin J., Guan M., Sima J., Gao G., Zhang M., Liu Z., Fant J., and Ma J.X. Decreased pigment epithelium-derived factor and increased vascular endothelial growth factor levels in pterygia. Cornea 22 (2003) 473-477
91. John H., Preissner K.T., Forssmann W.G., and Standker L. Novel glycosylated forms of human plasma endostatin and circulating endostatin-related fragments of collagen XV. Biochemistry 38 (1999) 10217-10224
92. John H., Radtke K., Standker L., and Forssmann W.G. Identification and characterization of novel endogenous proteolytic forms of the human angiogenesis inhibitors restin and endostatin. Biochim. Biophys. Acta 1747 (2005) 161-170
93. Johnson M.D., Kim H.R., Chesler L., Tsao-Wu G., Bouck N., and Polverini P.J. Inhibition of angiogenesis by tissue inhibitor of metalloproteinase. J. Cell Physiol 160 (1994) 194-202
94. Joukov V., Pajusola K., Kaipainen A., Chilov D., Lahtinen I., Kukk E., Saksela O., Kalkkinen N., and Alitalo K. A novel vascular endothelial growth factor, VEGF-C, is a ligand for the Flt4 (VEGFR-3) and KDR (VEGFR-2) receptor tyrosine kinases. EMBO J. 15 (1996) 1751
95. Joussen A.M., Poulaki V., Mitsiades N., Stechschulte S.U., Kirchhof B., Dartt D.A., Fong G.H., Rudge J., Wiegand S.J., Yancopoulos G.D., and Adamis A.P. VEGF-dependent conjunctivalization of the corneal surface. Invest Ophthalmol. Vis. Sci. 44 (2003) 117-123
96. Jung Y.D., Liu W., Reinmuth N., Ahmad S.A., Fan F., Gallick G.E., and Ellis L.M. Vascular endothelial growth factor is upregulated by interleukin-1 beta in human vascular smooth muscle cells via the P38 mitogen-activated protein kinase pathway. Angiogenesis. 4 (2001) 155-162
97. Junghans B.M., and Collin H.B. The limbal vascular response to corneal injury. An autoradiographic study. Cornea 8 (1989) 141-149
98. Kalluri R. Discovery of type IV collagen non-collagenous domains as novel integrin ligands and endogenous inhibitors of angiogenesis. Cold Spring Harb. Symp. Quant. Biol. 67 (2002) 255-266
99. Kalluri R. Basement membranes: structure, assembly and role in tumour angiogenesis. Nat. Rev. Cancer 3 (2003) 422-433
100. Kamiya K., Wang M., Uchida S., Amano S., Oshika T., Sakuragawa N., and Hori J. Topical application of culture supernatant from human amniotic epithelial cells suppresses inflammatory reactions in cornea. Exp. Eye Res. 80 (2005) 671-679
101. Kamphaus G.D., Colorado P.C., Panka D.J., Hopfer H., Ramchandran R., Torre A., Maeshima Y., Mier J.W., Sukhatme V.P., and Kalluri R. Canstatin, a novel matrix-derived inhibitor of angiogenesis and tumor growth. J. Biol. Chem. 275 (2000) 1209-1215
102. Karakousis P.C., John S.K., Behling K.C., Surace E.M., Smith J.E., Hendrickson A., Tang W.X., Bennett J., and Milam A.H. Localization of pigment epithelium derived factor (PEDF) in developing and adult human ocular tissues. Mol. Vis. 7 (2001) 154-163
103. Kato T., Kure T., Chang J.H., Gabison E.E., Itoh T., Itohara S., and Azar D.T. Diminished corneal angiogenesis in gelatinase A-deficient mice. FEBS Lett. 508 (2001) 187-190
104. Kato T., Chang J.H., and Azar D.T. Expression of type XVIII collagen during healing of corneal incisions and keratectomy wounds. Invest Ophthalmol. Vis. Sci. 44 (2003) 78-85
105. Kaufmann A., Salentin R., Gemsa D., and Sprenger H. Increase of CCR1 and CCR5 expression and enhanced functional response to MIP-1 alpha during differentiation of human monocytes to macrophages. J. Leukoc. Biol. 69 (2001) 248-252
106. Kenney M.C., Chwa M., Alba A., Saghizadeh M., Huang Z.S., and Brown D.J. Localization of TIMP-1, TIMP-2, TIMP-3, gelatinase A and gelatinase B in pathological human corneas. Curr. Eye Res. 17 (1998) 238-246
107. Kenyon K.R., and Tseng S.C. Limbal autograft transplantation for ocular surface disorders. Ophthalmology 96 (1989) 709-722
108. Kerbel R., and Folkman J. Clinical translation of angiogenesis inhibitors. Nat. Rev. Cancer 2 (2002) 727-739
109. Kim I., Ryan A.M., Rohan R., Amano S., Agular S., Miller J.W., and Adamis A.P. Constitutive expression of VEGF, VEGFR-1, and VEGFR-2 in normal eyes. Invest Ophthalmol. Vis. Sci. 40 (1999) 2115-2121
110. Kim J.C., and Tseng S.C. Transplantation of preserved human amniotic membrane for surface reconstruction in severely damaged rabbit corneas. Cornea 14 (1995) 473-484
111. Kim Y.M., Jang J.W., Lee O.H., Yeon J., Choi E.Y., Kim K.W., Lee S.T., and Kwon Y.G. Endostatin inhibits endothelial and tumor cellular invasion by blocking the activation and catalytic activity of matrix metalloproteinase. Cancer Res. 60 (2000) 5410-5413
112. Kim Y.M., Hwang S., Kim Y.M., Pyun B.J., Kim T.Y., Lee S.T., Gho Y.S., and Kwon Y.G. Endostatin blocks vascular endothelial growth factor-mediated signaling via direct interaction with KDR/Flk-1. J. Biol. Chem. 277 (2002) 27872-27879
113. Kinoshita S., Friend J., and Thoft R.A. Biphasic cell proliferation in transdifferentiation of conjunctival to corneal epithelium in rabbits. Invest Ophthalmol. Vis. Sci. 24 (1983) 1008-1014
114. Kivirikko S., Saarela J., Myers J.C., Autio-Harmainen H., and Pihlajaniemi T. Distribution of type XV collagen transcripts in human tissue and their production by muscle cells and fibroblasts. Am. J. Pathol. 147 (1995) 1500-1509
115. Koch A.E., Polverini P.J., Kunkel S.L., Harlow L.A., DiPietro L.A., Elner V.M., Elner S.G., and Strieter R.M. Interleukin-8 as a macrophage-derived mediator of angiogenesis. Science 258 (1992) 1798-1801
116. Koizumi N., Inatomi T., Suzuki T., Sotozono C., and Kinoshita S. Cultivated corneal epithelial stem cell transplantation in ocular surface disorders. Ophthalmology 108 (2001) 1569-1574
117. Kruse F.E., Chen J.J., Tsai R.J., and Tseng S.C. Conjunctival transdifferentiation is due to the incomplete removal of limbal basal epithelium. Invest Ophthalmol. Vis. Sci. 31 (1990) 1903-1913
118. Kruse F.E., and Tseng S.C. Transforming growth factors beta 1 and 2 inhibit proliferation of limbus and corneal epithelium. Ophthalmologe 91 (1994) 617-623
119. Kubo H., Cao R., Brakenhielm E., Makinen T., Cao Y., and Alitalo K. Blockade of vascular endothelial growth factor receptor-3 signaling inhibits fibroblast growth factor-2-induced lymphangiogenesis in mouse cornea. Proc. Natl. Acad. Sci. USA 99 (2002) 8868-8873
120. Kure T., Chang J.H., Kato T., Hernandez-Quintela E., Ye H., Lu P.C., Matrisian L.M., Gatinel D., Shapiro S., Gosheh F., Azar D.T., and Gosheh F. Corneal neovascularization after excimer keratectomy wounds in matrilysin-deficient mice. Invest Ophthalmol. Vis. Sci. 44 (2003) 137-144
121. Kuwano T., Nakao S., Yamamoto H., Tsuneyoshi M., Yamamoto T., Kuwano M., and Ono M. Cyclooxygenase 2 is a key enzyme for inflammatory cytokine-induced angiogenesis. FASEB J. 18 (2004) 300-310
122. Kvanta A., Sarman S., Fagerholm P., Seregard S., and Steen B. Expression of matrix metalloproteinase-2 (MMP-2) and vascular endothelial growth factor (VEGF) in inflammation-associated corneal neovascularization. Exp. Eye Res. 70 (2000) 419-428
123. Lam E., Tredget E.E., Marcoux Y., Li Y., and Ghahary A. Insulin suppresses collagenase stimulatory effect of stratifin in dermal fibroblasts. Mol. Cell Biochem. 266 (2004) 167-174
124. Lam E., Kilani R.T., Li Y., Tredget E.E., and Ghahary A. Stratifin-induced matrix metalloproteinase-1 in fibroblast is mediated by c-fos and p38 mitogen-activated protein kinase activation. J. Invest Dermatol. 125 (2005) 230-238
125. Lee S., Zheng M., Kim B., and Rouse B.T. Role of matrix metalloproteinase-9 in angiogenesis caused by ocular infection with herpes simplex virus. J. Clin. Invest 110 (2002) 1105-1111
126. Lee S.J., Jang J.W., Kim Y.M., Lee H.I., Jeon J.Y., Kwon Y.G., and Lee S.T. Endostatin binds to the catalytic domain of matrix metalloproteinase-2. FEBS Lett. 519 (2002) 147-152
127. Leffers H., Madsen P., Rasmussen H.H., Honore B., Andersen A.H., Walbum E., Vandekerckhove J., and Celis J.E. Molecular cloning and expression of the transformation sensitive epithelial marker stratifin. A member of a protein family that has been involved in the protein kinase C signalling pathway. J. Mol. Biol. 231 (1993) 982-998
128. Li D., Clark C.C., and Myers J.C. Basement membrane zone type XV collagen is a disulfide-bonded chondroitin sulfate proteoglycan in human tissues and cultured cells. J. Biol. Chem. 275 (2000) 22339-22347
129. Li D.Q., and Tseng S.C. Three patterns of cytokine expression potentially involved in epithelial-fibroblast interactions of human ocular surface. J. Cell Physiol 163 (1995) 61-79
130. Lijnen H.R., Ugwu F., Bini A., and Collen D. Generation of an angiostatin-like fragment from plasminogen by stromelysin-1 (MMP-3). Biochemistry 37 (1998) 4699-4702
131. Lin H.C., Chang J.H., Jain S., Gabison E.E., Kure T., Kato T., Fukai N., and Azar D.T. Matrilysin cleavage of corneal collagen type XVIII NC1 domain and generation of a 28-kDa fragment. Invest Ophthalmol. Vis. Sci. 42 (2001) 2517-2524
132. Ljubimov A.V., Burgeson R.E., Butkowski R.J., Michael A.F., Sun T.T., and Kenney M.C. Human corneal basement membrane heterogeneity: topographical differences in the expression of type IV collagen and laminin isoforms. Lab Invest. 72 (1995) 461-473
133. Ma D.H., Tsai R.J., Chu W.K., Kao C.H., and Chen J.K. Inhibition of vascular endothelial cell morphogenesis in cultures by limbal epithelial cells. Invest Ophthalmol. Vis. Sci. 40 (1999) 1822-1828
134. Ma D.H., Chen J.K., Kim W.S., Hao Y.X., Wu H.C., Tsai R.J., Hwang D.G., and Zhang F. Expression of matrix metalloproteinases 2 and 9 and tissue inhibitors of metalloproteinase 1 and 2 in inflammation-induced corneal neovascularization. Ophthalmic Res. 33 (2001) 353-362
135. Ma D.H., Chen J.I., Zhang F., Hwang D.G., and Chen J.K. Inhibition of fibroblast-induced angiogenic phenotype of cultured endothelial cells by the overexpression of tissue inhibitor of metalloproteinase (TIMP)-3. J. Biomed. Sci. 10 (2003) 526-534
136. Ma D.H., Zhang F., Shi W., Yao J.Y., Hsiao C.H., Wu H.C., Kim W.S., Hao Y.X., Hwang D.G., Chen J.K., and Tsai R.J. Expression of tissue inhibitor of metalloproteinase-4 in normal human corneal cells and experimental corneal neovascularization. Ophthalmic Res. 35 (2003) 199-207
137. Ma D.H., Yao J.Y., Yeh L.K., Liang S.T., See L.C., Chen H.T., Lin K.Y., Liang C.C., Lin K.K., and Chen J.K. In vitro antiangiogenic activity in ex vivo expanded human limbocorneal epithelial cells cultivated on human amniotic membrane. Invest Ophthalmol. Vis. Sci. 45 (2004) 2586-2595
138. Ma X., Ottino P., Bazan H.E., and Bazan N.G. Platelet-activating factor (PAF) induces corneal neovascularization and upregulates VEGF expression in endothelial cells. Invest Ophthalmol. Vis. Sci. 45 (2004) 2915-2921
139. Maeshima Y., Manfredi M., Reimer C., Holthaus K.A., Hopfer H., Chandamuri B.R., Kharbanda S., and Kalluri R. Identification of the anti-angiogenic site within vascular basement membrane-derived tumstatin. J. Biol. Chem. 276 (2001) 15240-15248
140. Maeshima Y., Sudhakar A., Lively J.C., Ueki K., Kharbanda S., Kahn C.R., Sonenberg N., Hynes R.O., and Kalluri R. Tumstatin, an endothelial cell-specific inhibitor of protein synthesis. Science 295 (2002) 140-143
141. Majima M., Hayashi I., Muramatsu M., Katada J., Yamashina S., and Katori M. Cyclo-oxygenase-2 enhances basic fibroblast growth factor-induced angiogenesis through induction of vascular endothelial growth factor in rat sponge implants. Br. J. Pharmacol. 130 (2000) 641-649
142. Mantovani A., Bussolino F., and Dejana E. Cytokine regulation of endothelial cell function. FASEB J. 6 (1992) 2591-2599
143. Marneros A.G., and Olsen B.R. The role of collagen-derived proteolytic fragments in angiogenesis. Matrix Biol. 20 (2001) 337-345
144. Marneros A.G., Keene D.R., Hansen U., Fukai N., Moulton K., Goletz P.L., Moiseyev G., Pawlyk B.S., Halfter W., Dong S., Shibata M., Li T., Crouch R.K., Bruckner P., and Olsen B.R. Collagen XVIII/endostatin is essential for vision and retinal pigment epithelial function. EMBO J. 23 (2004) 89-99
145. Marneros A.G., and Olsen B.R. Physiological role of collagen XVIII and endostatin. FASEB J. 19 (2005) 716-728
146. Maruyama K., Mori Y., Murasawa S., Masaki H., Takahashi N., Tsutusmi Y., Moriguchi Y., Shibazaki Y., Tanaka Y., Shibuya M., Inada M., Matsubara H., and Iwasaka T. Interleukin-1 beta upregulates cardiac expression of vascular endothelial growth factor and its receptor KDR/flk-1 via activation of protein tyrosine kinases. J. Mol. Cell Cardiol. 31 (1999) 607-617
147. Maruyama K., Ii M., Cursiefen C., Jackson D.G., Keino H., Tomita M., Van Rooijen N., Takenaka H., D'Amore P.A., Stein-Streilein J., Losordo D.W., and Streilein J.W. Inflammation-induced lymphangiogenesis in the cornea arises from CD11b-positive macrophages. J. Clin. Invest 115 (2005) 2363-2372
148. Masferrer J.L., Rimarachin J.A., Gerritsen M.E., Falck J.R., Yadagiri P., Dunn M.W., and Laniado-Schwartzman M. 12(R)-hydroxyeicosatrienoic acid, a potent chemotactic and angiogenic factor produced by the cornea. Exp. Eye Res. 52 (1991) 417-424
149. Mastyugin V., Aversa E., Bonazzi A., Vafaes C., Mieyal P., and Schwartzman M.L. Hypoxia-induced production of 12-hydroxyeicosanoids in the corneal epithelium: involvement of a cytochrome P-4504B1 isoform. J. Pharmacol. Exp. Ther. 289 (1999) 1611-1619
150. Mastyugin V., Mosaed S., Bonazzi A., Dunn M.W., and Schwartzman M.L. Corneal epithelial VEGF and cytochrome P450 4B1 expression in a rabbit model of closed eye contact lens wear. Curr. Eye Res. 23 (2001) 1-10
151. Menzel O., Bekkeheien R.C., Reymond A., Fukai N., Boye E., Kosztolanyi G., Aftimos S., Deutsch S., Scott H.S., Olsen B.R., Antonarakis S.E., and Guipponi M. Knobloch syndrome: novel mutations in COL18A1, evidence for genetic heterogeneity, and a functionally impaired polymorphism in endostatin. Hum. Mutat. 23 (2004) 77-84
152. Mezentsev A., Seta F., Dunn M.W., Ono N., Falck J.R., and Laniado-Schwartzman M. Eicosanoid regulation of vascular endothelial growth factor expression and angiogenesis in microvessel endothelial cells. J. Biol. Chem. 277 (2002) 18670-18676
153. Mezentsev A., Mastyugin V., Seta F., Ashkar S., Kemp R., Reddy D.S., Falck J.R., Dunn M.W., and Laniado-Schwartzman M. Transfection of cytochrome P4504B1 into the cornea increases angiogenic activity of the limbal vessels. J. Pharmacol. Exp. Ther. 315 (2005) 42-50
154. Mhawech P. 14-3-3 proteins-an update. Cell Res. 15 (2005) 228-236
155. Mieyal P.A., Dunn M.W., and Schwartzman M.L. Detection of endogenous 12-hydroxyeicosatrienoic acid in human tear film. Invest Ophthalmol. Vis. Sci. 42 (2001) 328-332
156. Mignatti P., and Rifkin D.B. Plasminogen activators and matrix metalloproteinases in angiogenesis. Enzyme Protein 49 (1996) 117-137
157. Mimura T., Amano S., Usui T., Kaji Y., Oshika T., and Ishii Y. Expression of vascular endothelial growth factor C and vascular endothelial growth factor receptor 3 in corneal lymphangiogenesis. Exp. Eye Res. 72 (2001) 71-78
158. Mirshahi M., Mirshahi S., Soria C., Soria J., Thomaidis A., Pouliquen Y., and Faure J.P. Production of proteases type plasminogen activator and their inhibitor in cornea. Biochem. Biophys. Res. Commun. 160 (1989) 1021-1025
159. Mohan R., Sivak J., Ashton P., Russo L.A., Pham B.Q., Kasahara N., Raizman M.B., and Fini M.E. Curcuminoids inhibit the angiogenic response stimulated by fibroblast growth factor-2, including expression of matrix metalloproteinase gelatinase B. J. Biol. Chem. 275 (2000) 10405-10412
160. Moore J.E., McMullen T.C., Campbell I.L., Rohan R., Kaji Y., Afshari N.A., Usui T., Archer D.B., and Adamis A.P. The inflammatory milieu associated with conjunctivalized cornea and its alteration with IL-1 RA gene therapy. Invest Ophthalmol. Vis. Sci. 43 (2002) 2905-2915
161. Moromizato Y., Stechschulte S., Miyamoto K., Murata T., Tsujikawa A., Joussen A.M., and Adamis A.P. CD18 and ICAM-1-dependent corneal neovascularization and inflammation after limbal injury. Am. J. Pathol. 157 (2000) 1277-1281
162. Moser T.L., Stack M.S., Asplin I., Enghild J.J., Hojrup P., Everitt L., Hubchak S., Schnaper H.W., and Pizzo S.V. Angiostatin binds ATP synthase on the surface of human endothelial cells. Proc. Natl. Acad. Sci. USA 96 (1999) 2811-2816
163. Moser T.L., Kenan D.J., Ashley T.A., Roy J.A., Goodman M.D., Misra U.K., Cheek D.J., and Pizzo S.V. Endothelial cell surface F1-F0 ATP synthase is active in ATP synthesis and is inhibited by angiostatin. Proc. Natl. Acad. Sci. USA 98 (2001) 6656-6661
164. Muller W.A., Weigl S.A., Deng X., and Phillips D.M. PECAM-1 is required for transendothelial migration of leukocytes. J. Exp. Med. 178 (1993) 449-460
165. Murphy A.N., Unsworth E.J., and Stetler-Stevenson W.G. Tissue inhibitor of metalloproteinases-2 inhibits bFGF-induced human microvascular endothelial cell proliferation. J. Cell Physiol. 157 (1993) 351-358
166. Nakagawa T., Li J.H., Garcia G., Mu W., Piek E., Bottinger E.P., Chen Y., Zhu H.J., Kang D.H., Schreiner G.F., Lan H.Y., and Johnson R.J. TGF-beta induces proangiogenic and antiangiogenic factors via parallel but distinct Smad pathways. Kidney Int. 66 (2004) 605-613
167. Nakao S., Kuwano T., Tsutsumi-Miyahara C., Ueda S., Kimura Y.N., Hamano S., Sonoda K.H., Saijo Y., Nukiwa T., Strieter R.M., Ishibashi T., Kuwano M., and Ono M. Infiltration of COX-2-expressing macrophages is a prerequisite for IL-1 beta-induced neovascularization and tumor growth. J. Clin. Invest 115 (2005) 2979-2991
168. Narayanan S., Glasser A., Hu Y.S., and McDermott A.M. The effect of interleukin-1 on cytokine gene expression by human corneal epithelial cells. Exp. Eye Res. 80 (2005) 175-183
169. Nishida K., Yamato M., Hayashida Y., Watanabe K., Maeda N., Watanabe H., Yamamoto K., Nagai S., Kikuchi A., Tano Y., and Okano T. Functional bioengineered corneal epithelial sheet grafts from corneal stem cells expanded ex vivo on a temperature-responsive cell culture surface. Transplantation 77 (2004) 379-385
170. Nishimura M., Schwartzman M.L., Falck J.R., Lumin S., Zirrolli J.A., and Murphy R.C. Metabolism of 12(R)-hydroxy-5,8,10,14-eicosatetraenoic acid (12(R)-HETE) in corneal tissues: formation of novel metabolites. Arch. Biochem. Biophys. 290 (1991) 326-335
171. O'Reilly M.S., Holmgren L., Shing Y., Chen C., Rosenthal R.A., Moses M., Lane W.S., Cao Y., Sage E.H., and Folkman J. Angiostatin: a novel angiogenesis inhibitor that mediates the suppression of metastases by a Lewis lung carcinoma. Cell 79 (1994) 315-328
172. O'Reilly M.S., Boehm T., Shing Y., Fukai N., Vasios G., Lane W.S., Flynn E., Birkhead J.R., Olsen B.R., and Folkman J. Endostatin: an endogenous inhibitor of angiogenesis and tumor growth. Cell 88 (1997) 277-285
173. Ogata N., Wada M., Otsuji T., Jo N., Tombran-Tink J., and Matsumura M. Expression of pigment epithelium-derived factor in normal adult rat eye and experimental choroidal neovascularization. Invest Ophthalmol. Vis. Sci. 43 (2002) 1168-1175
174. Ohgushi M., Kuroki S., Fukamachi H., O'Reilly L.A., Kuida K., Strasser A., and Yonehara S. Transforming growth factor beta-dependent sequential activation of Smad, Bim, and caspase-9 mediates physiological apoptosis in gastric epithelial cells. Mol. Cell Biol. 25 (2005) 10017-10028
175. Olofsson B., Pajusola K., Kaipainen A., von Euler G., Joukov V., Saksela O., Orpana A., Pettersson R.F., Alitalo K., and Eriksson U. Vascular endothelial growth factor B, a novel growth factor for endothelial cells. Proc. Natl. Acad. Sci. USA 93 (1996) 2576-2581
176. Ono M., Torisu H., Fukushi J., Nishie A., and Kuwano M. Biological implications of macrophage infiltration in human tumor angiogenesis. Cancer Chemother. Pharmacol. 43 Suppl (1999) S69-S71
177. Opbroek A., Kenney M.C., and Brown D. Characterization of a human corneal metalloproteinase inhibitor (TIMP-1). Curr. Eye Res. 12 (1993) 877-883
178. Ortega N., and Werb Z. New functional roles for non-collagenous domains of basement membrane collagens. J. Cell Sci. 115 (2002) 4201-4214
179. Ottino P., Taheri F., and Bazan H.E. Platelet-activating factor induces the gene expression of TIMP-1, -2, and PAI-1: imbalance between the gene expression of MMP-9 and TIMP-1 and -2. Exp. Eye Res. 74 (2002) 393-402
180. Overall C.M., and Kleifeld O. Tumour microenvironment-opinion: validating matrix metalloproteinases as drug targets and anti-targets for cancer therapy. Nat. Rev. Cancer 6 (2006) 227-239
181. Patterson B.C., and Sang Q.A. Angiostatin-converting enzyme activities of human matrilysin (MMP-7) and gelatinase B/type IV collagenase (MMP-9). J. Biol. Chem. 272 (1997) 28823-28825
182. Peek R., van Gelderen B.E., Bruinenberg M., and Kijlstra A. Molecular cloning of a new angiopoietinlike factor from the human cornea. Invest Ophthalmol. Vis. Sci. 39 (1998) 1782-1788
183. Pellegrini G., Traverso C.E., Franzi A.T., Zingirian M., Cancedda R., and De Luca M. Long-term restoration of damaged corneal surfaces with autologous cultivated corneal epithelium. Lancet 349 (1997) 990-993
184. Pfister R.R., Haddox J.L., and Sommers C.I. Alkali-degraded cornea generates a low molecular weight chemoattractant for polymorphonuclear leukocytes. Invest Ophthalmol. Vis. Sci. 34 (1993) 2297-2304
185. Pfister R.R., Haddox J.L., Sommers C.I., and Lam K.W. Identification and synthesis of chemotactic tripeptides from alkali-degraded whole cornea. A study of N-acetyl-proline-glycine-proline and N-methyl-proline-glycine-proline. Invest Ophthalmol. Vis. Sci. 36 (1995) 1306-1316
186. Philipp W., Speicher L., and Humpel C. Expression of vascular endothelial growth factor and its receptors in inflamed and vascularized human corneas. Invest Ophthalmol. Vis. Sci. 41 (2000) 2514-2522
187. Rabbani S.A. Metalloproteases and urokinase in angiogenesis and tumor progression. In vivo 12 (1998) 135-142
188. Rama P., Bonini S., Lambiase A., Golisano O., Paterna P., De Luca M., and Pellegrini G. Autologous fibrin-cultured limbal stem cells permanently restore the corneal surface of patients with total limbal stem cell deficiency. Transplantation 72 (2001) 1478-1485
189. Ramchandran R., Dhanabal M., Volk R., Waterman M.J., Segal M., Lu H., Knebelmann B., and Sukhatme V.P. Antiangiogenic activity of restin, NC10 domain of human collagen XV: comparison to endostatin. Biochem. Biophys. Res. Commun. 255 (1999) 735-739
190. Raport C.J., Gosling J., Schweickart V.L., Gray P.W., and Charo I.F. Molecular cloning and functional characterization of a novel human CC chemokine receptor (CCR5) for RANTES, MIP-1beta, and MIP-1alpha. J. Biol. Chem. 271 (1996) 17161-17166
191. Raza S.L., and Cornelius L.A. Matrix metalloproteinases: pro- and anti-angiogenic activities. J. Invest. Dermatol. Symp. Proc. 5 (2000) 47-54
192. Rehn M., Veikkola T., Kukk-Valdre E., Nakamura H., Ilmonen M., Lombardo C., Pihlajaniemi T., Alitalo K., and Vuori K. Interaction of endostatin with integrins implicated in angiogenesis. Proc. Natl. Acad. Sci. USA 98 (2001) 1024-1029
193. Sack R.A., Beaton A.R., and Sathe S. Diurnal variations in angiostatin in human tear fluid: a possible role in prevention of corneal neovascularization. Curr. Eye Res. 18 (1999) 186-193
194. Saika S. TGF-beta signal transduction in corneal wound healing as a therapeutic target. Cornea 23 (2004) S25-S30
195. Saika S. TGF-beta pathobiology in the eye. Lab Invest. 86 (2006) 106-115
196. Saika S., Okada Y., Miyamoto T., Yamanaka O., Ohnishi Y., Yamanaka A., and Ooshima A. Protein expression pattern of collagen type XV in mouse cornea. Graefes Arch. Clin. Exp. Ophthalmol. 242 (2004) 432-436
197. Saika S., Ikeda K., Yamanaka O., Miyamoto T., Ohnishi Y., Sato M., Muragaki Y., Ooshima A., Nakajima Y., Kao W.W., Flanders K.C., and Roberts A.B. Expression of Smad7 in mouse eyes accelerates healing of corneal tissue after exposure to alkali. Am. J. Pathol. 166 (2005) 1405-1418
198. Salven P., Hattori K., Heissig B., and Rafii S. Interleukin-1alpha promotes angiogenesis in vivo via VEGFR-2 pathway by inducing inflammatory cell VEGF synthesis and secretion. FASEB J. 16 (2002) 1471-1473
199. Samolov B., Steen B., Seregard S., van d.P.I., Montan P., and Kvanta A. Delayed inflammation-associated corneal neovascularization in MMP-2-deficient mice. Exp. Eye Res. 80 (2005) 159-166
200. Samson C.M., Nduaguba C., Baltatzis S., and Foster C.S. Limbal stem cell transplantation in chronic inflammatory eye disease. Ophthalmology 109 (2002) 862-868
201. Sang Q.X. Complex role of matrix metalloproteinases in angiogenesis. Cell Res. 8 (1998) 171-177
202. Sawaoka H., Tsuji S., Tsujii M., Gunawan E.S., Sasaki Y., Kawano S., and Hori M. Cyclooxygenase inhibitors suppress angiogenesis and reduce tumor growth in vivo. Lab Invest. 79 (1999) 1469-1477
203. Schnaper H.W., Grant D.S., Stetler-Stevenson W.G., Fridman R., D'Orazi G., Murphy A.N., Bird R.E., Hoythya M., Fuerst T.R., and French D.L. Type IV collagenase(s) and TIMPs modulate endothelial cell morphogenesis in vitro. J. Cell Physiol. 156 (1993) 235-246
204. Schuster N., and Krieglstein K. Mechanisms of TGF-beta-mediated apoptosis. Cell Tissue Res. 307 (2002) 1-14
205. Schwab I.R., Reyes M., and Isseroff R.R. Successful transplantation of bioengineered tissue replacements in patients with ocular surface disease. Cornea 19 (2000) 421-426
206. Sekiyama E., Nakamura T., Cooper L.J., Kawasaki S., Hamuro J., Fullwood N.J., and Kinoshita S. Unique distribution of thrombospondin-1 in human ocular surface epithelium. Invest Ophthalmol. Vis. Sci. 47 (2006) 1352-1358
207. Shapiro M.S., Friend J., and Thoft R.A. Corneal re-epithelialization from the conjunctiva. Invest Ophthalmol. Vis. Sci. 21 (1981) 135-142
208. Shichiri M., and Hirata Y. Antiangiogenesis signals by endostatin. FASEB J. 15 (2001) 1044-1053
209. Shimazaki J., Aiba M., Goto E., Kato N., Shimmura S., and Tsubota K. Transplantation of human limbal epithelium cultivated on amniotic membrane for the treatment of severe ocular surface disorders. Ophthalmology 109 (2002) 1285-1290
210. Sivak J.M., and Fini M.E. MMPs in the eye: emerging roles for matrix metalloproteinases in ocular physiology. Prog. Retin. Eye Res. 21 (2002) 1-14
211. Solomon A., Rosenblatt M., Monroy D., Ji Z., Pflugfelder S.C., and Tseng S.C. Suppression of interleukin 1alpha and interleukin 1beta in human limbal epithelial cells cultured on the amniotic membrane stromal matrix. Br. J. Ophthalmol. 85 (2001) 444-449
212. Sonoda K.H., Nakao S., Nakamura T., Oshima T., Qiao H., Hisatomi T., Kinoshita S., and Ishibashi T. Cellular events in the normal and inflamed cornea. Cornea 24 (2005) S50-S54
213. Sotozono C., He J., Matsumoto Y., Kita M., Imanishi J., and Kinoshita S. Cytokine expression in the alkali-burned cornea. Curr. Eye Res. 16 (1997) 670-676
214. Sottile J. Regulation of angiogenesis by extracellular matrix. Biochim. Biophys. Acta 1654 (2004) 13-22
215. Standker L., Schrader M., Kanse S.M., Jurgens M., Forssmann W.G., and Preissner K.T. Isolation and characterization of the circulating form of human endostatin. FEBS Lett. 420 (1997) 129-133
216. Stoltz R.A., Conners M.S., Dunn M.W., and Schwartzman M.L. Effect of metabolic inhibitors on arachidonic acid metabolism in the corneal epithelium: evidence for cytochrome P450-mediated reactions. J. Ocul. Pharmacol. 10 (1994) 307-317
217. Stoltz R.A., and Schwartzman M.L. High affinity binding sites for 12(R)-Hydroxyeicosatrienoic acid [12(R)-HETrE] in microvessel endothelial cells. J. Ocul. Pharmacol. Ther. 13 (1997) 191-199
218. Strieter R.M., Kunkel S.L., Elner V.M., Martonyi C.L., Koch A.E., Polverini P.J., and Elner S.G. Interleukin-8. A corneal factor that induces neovascularization. Am. J. Pathol. 141 (1992) 1279-1284
219. Sun C.C., Su Pang J.H., Cheng C.Y., Cheng H.F., Lee Y.S., Ku W.C., Hsiao C.H., Chen J.K., and Yang C.M. Interleukin-1 Receptor Antagonist (IL-1RA) Prevents Apoptosis in ex vivo Expansion of Human Limbal Epithelial Cells Cultivated on Human Amniotic Membrane. Stem Cells 24 (2006) 2130-2139
220. Sunderkotter C., Steinbrink K., Goebeler M., Bhardwaj R., and Sorg C. Macrophages and angiogenesis. J. Leukoc. Biol. 55 (1994) 410-422
221. Suzuki O.T., Sertie A.L., Der K.V., Kok F., Carpenter M., Murray J., Czeizel A.E., Kliemann S.E., Rosemberg S., Monteiro M., Olsen B.R., and Passos-Bueno M.R. Molecular analysis of collagen XVIII reveals novel mutations, presence of a third isoform, and possible genetic heterogeneity in Knobloch syndrome. Am. J. Hum. Genet. 71 (2002) 1320-1329
222. Tao Y., Bazan H.E., and Bazan N.G. Platelet-activating factor induces the expression of metalloproteinases-1 and -9, but not -2 or -3, in the corneal epithelium. Invest Ophthalmol. Vis. Sci. 36 (1995) 345-354
223. Tao Y., Bazan H.E., and Bazan N.G. Platelet-activating factor enhances urokinase-type plasminogen activator gene expression in corneal epithelium. Invest Ophthalmol. Vis. Sci. 37 (1996) 2037-2046
224. Tarui T., Miles L.A., and Takada Y. Specific interaction of angiostatin with integrin alpha(v)beta(3) in endothelial cells. J. Biol. Chem. 276 (2001) 39562-39568
225. Tervo T., Tervo K., van Setten G.B., Virtanen I., and Tarkkanen A. Plasminogen activator and its inhibitor in the experimental corneal wound. Exp. Eye Res. 48 (1989) 445-449
226. Thoft R.A., and Friend J. Biochemical transformation of regenerating ocular surface epithelium. Invest Ophthalmol. Vis. Sci. 16 (1977) 14-20
227. Tsai R.J., Sun T.T., and Tseng S.C. Comparison of limbal and conjunctival autograft transplantation in corneal surface reconstruction in rabbits. Ophthalmology 97 (1990) 446-455
228. Tsai R.J., Ho Y.S., and Chen J.K. The effects of fibroblasts on the growth and differentiation of human bulbar conjunctival epithelial cells in an in vitro conjunctival equivalent. Invest Ophthalmol. Vis. Sci. 35 (1994) 2865-2875
229. Tsai R.J., and Tseng S.C. Human allograft limbal transplantation for corneal surface reconstruction. Cornea 13 (1994) 389-400
230. Tsai R.J., and Tseng S.C. Effect of stromal inflammation on the outcome of limbal transplantation for corneal surface reconstruction. Cornea 14 (1995) 439-449
231. Tsai R.J., Li L.M., and Chen J.K. Reconstruction of damaged corneas by transplantation of autologous limbal epithelial cells. N. Engl. J. Med. 343 (2000) 86-93
232. Tseng S.C., Hirst L.W., Farazdaghi M., and Green W.R. Goblet cell density and vascularization during conjunctival transdifferentiation. Invest Ophthalmol. Vis. Sci. 25 (1984) 1168-1176
233. Tseng S.C., Farazdaghi M., and Rider A.A. Conjunctival transdifferentiation induced by systemic vitamin A deficiency in vascularized rabbit corneas. Invest Ophthalmol. Vis. Sci. 28 (1987) 1497-1504
234. Tsubota K., Satake Y., Kaido M., Shinozaki N., Shimmura S., Bissen-Miyajima H., and Shimazaki J. Treatment of severe ocular-surface disorders with corneal epithelial stem-cell transplantation. N. Engl. J. Med. 340 (1999) 1697-1703
235. Twining S.S., Wilson P.M., and Ngamkitidechakul C. Extrahepatic synthesis of plasminogen in the human cornea is up-regulated by interleukins-1alpha and -1beta. Biochem. J. 339 Pt 3 (1999) 705-712
236. Undevia N.S., Dorscheid D.R., Marroquin B.A., Gugliotta W.L., Tse R., and White S.R. Smad and p38-MAPK signaling mediates apoptotic effects of transforming growth factor-beta1 in human airway epithelial cells. Am. J. Physiol. Lung Cell Mol. Physiol. 287 (2004) L515-L524
237. Urano T., Takahashi S., Suzuki T., Fujimura T., Fujita M., Kumagai J., Horie-Inoue K., Sasano H., Kitamura T., Ouchi Y., and Inoue S. 14-3-3sigma is down-regulated in human prostate cancer. Biochem. Biophys. Res. Commun. 319 (2004) 795-800
238. Usui T., Ishida S., Yamashiro K., Kaji Y., Poulaki V., Moore J., Moore T., Amano S., Horikawa Y., Dartt D., Golding M., Shima D.T., and Adamis A.P. VEGF164(165) as the pathological isoform: differential leukocyte and endothelial responses through VEGFR1 and VEGFR2. Invest Ophthalmol. Vis. Sci. 45 (2004) 368-374
239. Vafeas C., Mieyal P.A., Urbano F., Falck J.R., Chauhan K., Berman M., and Schwartzman M.L. Hypoxia stimulates the synthesis of cytochrome P450-derived inflammatory eicosanoids in rabbit corneal epithelium. J. Pharmacol. Exp. Ther. 287 (1998) 903-910
240. van Setten G.B. Vascular endothelial growth factor (VEGF) in normal human corneal epithelium: detection and physiological importance. Acta Ophthalmol. Scand. 75 (1997) 649-652
241. Van D.V., Broersma L., Dijkstra C.D., Van Rooijen N., Van Rij G., and Van der G.R. Prevention of corneal allograft rejection in rats treated with subconjunctival injections of liposomes containing dichloromethylene diphosphonate. Invest Ophthalmol. Vis. Sci. 35 (1994) 3505-3515
242. Vaporciyan A.A., DeLisser H.M., Yan H.C., Mendiguren I.I., Thom S.R., Jones M.L., Ward P.A., and Albelda S.M. Involvement of platelet-endothelial cell adhesion molecule-1 in neutrophil recruitment in vivo. Science 262 (1993) 1580-1582
243. Veitonmaki N., Cao R., Wu L.H., Moser T.L., Li B., Pizzo S.V., Zhivotovsky B., and Cao Y. Endothelial cell surface ATP synthase-triggered caspase-apoptotic pathway is essential for k1-5-induced antiangiogenesis. Cancer Res. 64 (2004) 3679-3686
244. Vinores S.A., Xiao W.H., Zimmerman R., Whitcup S.M., and Wawrousek E.F. Upregulation of vascular endothelial growth factor (VEGF) in the retinas of transgenic mice overexpressing interleukin-1beta (IL-1beta) in the lens and mice undergoing retinal degeneration. Histol. Histopathol. 18 (2003) 797-810
245. Vogten J.M., Reijerkerk A., Meijers J.C., Voest E.E., Borel R.I., and Gebbink M.F. The role of the fibrinolytic system in corneal angiogenesis. Angiogenesis 6 (2003) 311-316
246. von Mohrenfels C.W., Reischl U., Gabler B., and Lohmann C.P. Corneal haze after photorefractive keratectomy. Role of individual collagen type IV synthesis on postoperative corneal opacity. Ophthalmologe 99 (2002) 532-537
247. Vu T.H., Shipley J.M., Bergers G., Berger J.E., Helms J.A., Hanahan D., Shapiro S.D., Senior R.M., and Werb Z. MMP-9/gelatinase B is a key regulator of growth plate angiogenesis and apoptosis of hypertrophic chondrocytes. Cell 93 (1998) 411-422
248. Wallace G.R., John C.S., Wloka K., Salmon M., and Murray P.I. The role of chemokines and their receptors in ocular disease. Prog. Retin. Eye Res. 23 (2004) 435-448
249. Wang M., Liu Y.E., Greene J., Sheng S., Fuchs A., Rosen E.M., and Shi Y.E. Inhibition of tumor growth and metastasis of human breast cancer cells transfected with tissue inhibitor of metalloproteinase 4. Oncogene 14 (1997) 2767-2774
250. Warejcka D.J., Vaughan K.A., Bernstein A.M., and Twining S.S. Differential conversion of plasminogen to angiostatin by human corneal cell populations. Mol. Vis. 11 (2005) 859-868
251. Wen W., Moses M.A., Wiederschain D., Arbiser J.L., and Folkman J. The generation of endostatin is mediated by elastase. Cancer Res. 59 (1999) 6052-6056
252. Wickstrom S.A., Veikkola T., Rehn M., Pihlajaniemi T., Alitalo K., and Keski-Oja J. Endostatin-induced modulation of plasminogen activation with concomitant loss of focal adhesions and actin stress fibers in cultured human endothelial cells. Cancer Res. 61 (2001) 6511-6516
253. Wickstrom S.A., Alitalo K., and Keski-Oja J. Endostatin associates with integrin alpha5beta1 and caveolin-1, and activates Src via a tyrosyl phosphatase-dependent pathway in human endothelial cells. Cancer Res. 62 (2002) 5580-5589
254. Wickstrom S.A., Alitalo K., and Keski-Oja J. Endostatin associates with lipid rafts and induces reorganization of the actin cytoskeleton via down-regulation of RhoA activity. J. Biol. Chem. 278 (2003) 37895-37901
255. Williams D.L., Risse B., Kim S., Saunders D., Orlin S., Baker M.S., Jensen P.J., and Lavker R.M. Plasminogen activator inhibitor type 2 in human corneal epithelium. Invest Ophthalmol. Vis. Sci. 40 (1999) 1669-1675
256. Wilson S.E., Mohan R.R., Mohan R.R., Ambrosio Jr. R., Hong J., and Lee J. The corneal wound healing response: cytokine-mediated interaction of the epithelium, stroma, and inflammatory cells. Prog. Retin. Eye Res. 20 (2001) 625-637
257. Witmer A.N., Vrensen G.F., Van Noorden C.J., and Schlingemann R.O. Vascular endothelial growth factors and angiogenesis in eye disease. Prog. Retin. Eye Res. 22 (2003) 1-29
258. Xu J., Rodriguez D., Petitclerc E., Kim J.J., Hangai M., Moon Y.S., Davis G.E., Brooks P.C., and Yuen S.M. Proteolytic exposure of a cryptic site within collagen type IV is required for angiogenesis and tumor growth in vivo. J. Cell Biol. 154 (2001) 1069-1079
259. Yamada J., Dana M.R., Sotozono C., and Kinoshita S. Local suppression of IL-1 by receptor antagonist in the rat model of corneal alkali injury. Exp. Eye Res. 76 (2003) 161-167
260. Yamada Y., Nezu J., Shimane M., and Hirata Y. Molecular cloning of a novel vascular endothelial growth factor, VEGF-D. Genomics 42 (1997) 483-488
261. Yang H., Zhao R., and Lee M.H. 14-3-3sigma, a p53 regulator, suppresses tumor growth of nasopharyngeal carcinoma. Mol. Cancer Ther. 5 (2006) 253-260
262. Yang H.Y., Wen Y.Y., Chen C.H., Lozano G., and Lee M.H. 14-3-3 sigma positively regulates p53 and suppresses tumor growth. Mol. Cell Biol. 23 (2003) 7096-7107
263. Yang Y.A., Tang B., Robinson G., Hennighausen L., Brodie S.G., Deng C.X., and Wakefield L.M. Smad3 in the mammary epithelium has a nonredundant role in the induction of apoptosis, but not in the regulation of proliferation or differentiation by transforming growth factor-beta. Cell Growth Differ. 13 (2002) 123-130
264. Yoshida S., Ono M., Shono T., Izumi H., Ishibashi T., Suzuki H., and Kuwano M. Involvement of interleukin-8, vascular endothelial growth factor, and basic fibroblast growth factor in tumor necrosis factor alpha-dependent angiogenesis. Mol. Cell Biol. 17 (1997) 4015-4023
265. Yoshimura T., Yuhki N., Moore S.K., Appella E., Lerman M.I., and Leonard E.J. Human monocyte chemoattractant protein-1 (MCP-1). Full-length cDNA cloning, expression in mitogen-stimulated blood mononuclear leukocytes, and sequence similarity to mouse competence gene JE. FEBS Lett. 244 (1989) 487-493
266. Zhang H., Li C., and Baciu P.C. Expression of integrins and MMPs during alkaline-burn-induced corneal angiogenesis. Invest Ophthalmol. Vis. Sci. 43 (2002) 955-962
267. Zhou Z., Apte S.S., Soininen R., Cao R., Baaklini G.Y., Rauser R.W., Wang J., Cao Y., and Tryggvason K. Impaired endochondral ossification and angiogenesis in mice deficient in membrane-type matrix metalloproteinase I. Proc. Natl. Acad. Sci. USA 97 (2000) 4052-4057
268. Zhu S.N., and Dana M.R. Expression of cell adhesion molecules on limbal and neovascular endothelium in corneal inflammatory neovascularization. Invest Ophthalmol. Vis. Sci. 40 (1999) 1427-1434